The Congressional Progressive Caucus held a Medicare for All hearing on July 22, 2026, with more than half of House Democrats co-sponsoring single-payer legislation. Dr. Diljeet K. Singh of Physicians for a National Health Plan testified that at least 35 cents of every healthcare dollar is lost to insurance administration and corporate profit. A 2020 Yale epidemiological study cited at the hearing projected that Medicare for All would save an estimated 68,000 lives per year while reducing national healthcare spending by about $450 billion. The U.S. uninsured population stands at 28 million, an increase since 2023, and health outcomes are worse than comparable single-payer nations on life expectancy and infant mortality despite per-capita spending roughly twice as high. The hearing record from which these figures come provides the substrate for tracing why the gap between this evidence and any legislative advance persists.

The procedural wall

Senate Rule XXII requires 60 votes for cloture on ordinary legislation. Democrats have not held 60 seats since briefly in 2009–2010. Budget reconciliation, the workaround used for the 2017 Tax Cuts and Jobs Act and the Republican One Big Beautiful Bill Act that cut Medicaid and allowed ACA subsidies to expire weeks before the hearing, is unavailable for comprehensive single-payer restructuring. The Byrd Rule (Section 313 of the Congressional Budget Act, 2 U.S.C. § 644) constrains reconciliation to provisions with direct budgetary impact; a single-payer transition raises points of order for provisions the parliamentarian may deem “merely incidental” to the budget. Waiving Byrd Rule points of order itself requires 60 votes, nesting the supermajority requirement: the device that would bypass the supermajority requirement is blocked by a supermajority requirement.

A five-whys descent establishes the procedural chain as terminal — no deeper procedural mechanism underlies Senate Rule XXII. The chain runs from floor access to filibuster to reconciliation blocked to Byrd Rule irremovable without its own supermajority. One framing in the analysis treats this procedural barrier as the root cause: removal (filibuster reform or a Byrd Rule waiver) would enable passage of the existing co-sponsor coalition’s bill. Confidence in this chain is moderate-high — the barrier is grounded in verifiable institutional rules and the mechanism is documented — but the dominant uncertainty is whether removing the procedural barrier would actually produce passage. Whip counts, member-level opposition independent of industry lobbying, and presidential veto threat are not captured in the procedural analysis.

The One Big Beautiful Bill Act simultaneously grew the uninsured population and consumed reconciliation capacity for the remainder of the congressional cycle, narrowing the legislative window for any comprehensive coverage legislation.

The self-reinforcing cycle: policy architecture and its defenders

The multi-payer insurance architecture requires each insurer to maintain duplicate claims processing, coding, utilization review, and marketing infrastructure. Singh testified that this duplication wastes “at least 35 cents of every healthcare dollar” on functions that do not deliver patient care. The figure is consistent with the upper bound of published administrative-waste estimates — the Himmelstein et al. landmark study found U.S. administration at approximately 34.2 percent of national health expenditures. The 35-cent figure bundles genuine administrative waste with functions that would transfer to a public payer under single-payer (enrollment, quality reporting, fraud prevention, clinical coordination), meaning net job displacement for insurance-industry workers and healthcare administrators — while likely substantial — would be smaller than the raw percentage implies; a single-payer system would create new public-sector administrative positions.

The profit extraction enabled by the multi-payer architecture funds the healthcare-industry lobbying infrastructure that defends it. Rep. Greg Casar cited multimillion-dollar CEO salaries and millions of dollars in healthcare-industry lobbying spending in response to Republican criticisms that single-payer would be too costly. The post-Citizens United v. FEC (558 U.S. 310, 2010) campaign-finance regime permits unlimited independent expenditures by corporations, structurally amplifying concentrated industry spending relative to diffuse public interest. This is the convergent deeper political-economy enabler that sustains the procedural barrier.

A second framing treats the multi-payer for-profit insurance architecture as the root cause: removal of that architecture (enacting a single-payer mechanism) would eliminate the structural feature that generates the 35 percent waste and funds the lobbying infrastructure that defends it. The lobbying feedback loop is treated in this framing as a contributing factor that sustains the architecture, not as the root itself. The relationship between the two framings is causal in both directions: each treats the other’s root as a contributor. The procedural barrier blocks removal of the architectural root; the architectural root is the condition the procedure prevents changing. The consolidated analysis preserves this as a genuine, unresolved analytical tension.

The stakeholder map: asymmetry as the central finding

The hearing’s stakeholder landscape is defined by a structural asymmetry. The parties with the greatest material interest in the policy outcome — the 28 million uninsured, future patients, communities facing environmental health burdens — are the least formally organized. The parties with the most to lose from passage — private insurers, pharmaceutical companies, hospital systems with favorable payer mixes, large employers offering employer-sponsored insurance — were not at the hearing. Their absence is itself the most consequential feature of the map.

The convening coalition holds high power and high interest. The Congressional Progressive Caucus (Pramila Jayapal, Debbie Dingell, Greg Casar, Jesús “Chuy” García, Adelita Grijalva, Melanie Stansbury; 100-plus co-sponsors, more than half of House Democrats) serves as convenors and legislative sponsors — classified as a Definitive stakeholder in the Mitchell-Agile-Wood salience framework (power, legitimacy, and urgency all high). National Nurses United, with president Jamie Brown testifying, is likewise Definitive: the largest nurses’ union in the U.S., frontline clinical credibility, and an active ongoing crisis of understaffing and high patient loads. Physicians for a National Health Program and Public Citizen fall into the Dominant category (power and legitimacy high, urgency moderate — their reform agenda is continuous rather than tied to an acute event).

The absent coalition — the silent actors whose power does not require them to appear — comprises private health insurers (UnitedHealth, Anthem/Carelon, Cigna, Aetna/CVS; roughly $1.5 trillion in annual premiums industry-wide), hospital systems and associations (the American Hospital Association and Federation of American Hospitals, the largest employers in most congressional districts), the pharmaceutical industry (PhRMA and individual manufacturers, among the top lobbying spenders), employers offering employer-sponsored insurance, and state governments as Medicaid administrators. All are classified as Dominant stakeholders: very high power and recognized legitimacy, with urgency moderated by the absence of an immediate legislative threat.

The internal tensions within this status-quo coalition are real and would become salient under legislative pressure: pharmaceutical companies and private insurers diverge on drug pricing (insurers would benefit from government-negotiated rates that lower claims costs); safety-net hospitals and high-margin hospital systems diverge on payment models (safety-nets gain guaranteed government payment under single-payer while high-margin systems lose favorable private-payer mixes); large self-insured employers and small fully-insured employers diverge on cost-shift versus plan choice (self-insureds could theoretically align with single-payer cost reduction). These tensions remain latent so long as no legislative vehicle advances.

The dependent stakeholders — high legitimacy and urgency, low power — include the 28 million uninsured (no uninsured individual testified by name; advocacy organizations spoke on their behalf), rural communities facing hospital closures (not mentioned in the hearing or article), insurance-industry workers and healthcare administrators (their livelihoods embedded in the 35-cent-per-dollar overhead figure), communities of color and environmental-justice populations (Grijalva’s superfund-site testimony is the closest proxy), and future generations (Sen. Andy Kim’s children’s Medicare bill, introduced the day before the hearing, is the closest institutional proxy). The function of the testimony at the hearing was to transfer legitimacy and urgency from these dependent stakeholders to the Definitive actors who can act — an effective advocacy strategy, but one that mirrors existing power asymmetries rather than disclosing new fault lines.

The absent-coalition observation that ties the analysis together: the procedural barrier is the political expression of the power asymmetry the map discloses. The same industries that do not need to show up at a hearing are the ones whose lobbying expenditures sustain the 60-vote blockade.

The polling distortion

The center-left Searchlight Institute has urged Democrats to refrain from endorsing Medicare for All, citing a June poll by Tavern Research. That survey found either a majority or plurality in support of single-payer healthcare but also found that 70 percent of respondents preferred to keep their current health insurance. The detail surfaced at the hearing: 45 percent of those surveyed already received coverage through Medicare or Medicaid — populations that would retain or gain coverage under single-payer. The instrument conflates satisfaction with existing public insurance into a figure that appears to measure resistance to public insurance, producing a systematically misleading top-line result.

A separate November poll by the Medicare for All PAC found 52 percent of respondents favored a Democratic candidate who backed the policy, compared with 45 percent who supported a Republican candidate on a standard GOP health platform. Among Democratic voters, support for universal healthcare reached 90 percent.

The two polls are not directly comparable — different sponsors, methodologies, and question framings — but the structural effect is clear. The distorted number enters the strategic calculus of lawmakers and party operatives. Searchlight Institute functions as a broker between coalitions, offering the status-quo coalition an empirical tool in the Tavern Research finding while operating in an unspoken alignment with healthcare corporations: both benefit from the current arrangement, the former from electoral caution and the latter from profit. The polling distortion completes the feedback loop. The same architecture that generates the 35-cent administrative waste also generates, through the polling ecosystem, an information signal that discourages political action against it.

The Yale study and the evidence on outcomes

The 2020 Yale epidemiological study (Galvani et al., The Lancet) projects that Medicare for All would save 68,000 lives annually and reduce U.S. healthcare spending by roughly 13 percent, or about $450 billion. The mechanism — reallocating administrative waste to patient care improves outcomes — is clear and consistent with cross-national comparisons showing single-payer systems achieve better outcomes at lower per-capita cost. The study’s projections are modeled estimates from a counterfactual comparison, not observed data from a controlled experiment. Confounding factors (population health differences, drug pricing, provider payment rates) cannot be ruled out. The evidence is rated moderately strong — mechanism plus consistent cross-national correlation — but not fully demonstrated.

Debbie Dingell’s framing at the hearing connected the evidence directly to the structural diagnosis: the United States spends twice as much per person on healthcare as other countries that operate single-payer systems, yet has 28 million residents without insurance, lower life expectancy, and higher infant mortality. “The only people benefiting are the corporations who are profiting while Americans are struggling,” she said.

Legislator testimony as evidentiary grounding

The hearing’s testimony supply the evidentiary substrate for the structural analysis. Debbie Dingell located the Medicare for All project in her family’s multigenerational legislative history: her father-in-law, John D. Dingell Sr., drafted the universal healthcare legislation that laid the foundation for Medicare; her late husband, John Dingell, introduced Medicare for All legislation repeatedly over his decades in Congress. “I’m going to get this over the finish line before I die, and I don’t plan on dying soon. But I’d like to get it done,” she said.

Pramila Jayapal closed the hearing with a statement that frames the temporal moment — “the current system has collapsed under the weight of for-profit insurance companies” — and the political bet — “I believe the American people across party line are with us, and are looking for transformative system where everyone is in and nobody is out, and healthcare is truly a human right.”

Greg Casar called Medicare for All the Progressive Caucus’s “number one priority for reforming our healthcare system” and argued it should be the Democratic Party’s top priority. Jesús “Chuy” García made the structural-institutional case: “Healthcare should not be a privilege determined by your job, your income, or your zip code. Yet millions of Americans continue to delay or forgo care because they simply cannot afford it.”

Adelita Grijalva brought the environmental-health dimension: growing up near a superfund site, losing family members to cancer, requiring a hysterectomy at an early age — urging lawmakers to “address the underlying causes of this sickness of the system, not just treat the symptoms.”

Melanie Stansbury contrasted the $37.5 billion cost of the Trump administration’s war in Iran with criticisms of universal healthcare spending: “There is no person that should die because they’re afraid to go to the emergency room.”

Jamie Brown of National Nurses United described understaffed units and high patient loads attributed to healthcare employers prioritizing profits over care. “The only way to transform our system for the better is to ensure that the profit motive is completely removed from the equation,” she said.

Sen. Andy Kim introduced legislation the day before the hearing that would enroll all children in Medicare automatically until age 26 — a flanking incrementalist move that builds momentum toward universal coverage without directly challenging the single-payer bill’s primacy, and the closest institutional proxy for future generations identified in the stakeholder map.

What the analysis cannot resolve

The forward-looking scenario dimension — what would actually happen if the procedural barrier were removed — is absent from this analysis. The scenario-planning module’s deliverable was withheld as broken. On the structural evidence available, two legislative paths serve as bookends rather than formal scenarios with probabilities:

Most likely — stalemate persists. The procedural barrier remains terminal through the current Congress. The One Big Beautiful Bill Act has consumed the reconciliation vehicle. Medicaid cuts and ACA subsidy expiration grow the uninsured count without creating a legislative opening. Incremental measures advance as messaging vehicles but face the same 60-vote wall. The self-reinforcing cycle continues. The polling distortion continues to circulate as a cautionary signal. The absent industries remain structurally insulated. The gap between evidence and policy widens.

Most disruptive — filibuster reform opens the procedural door. A triggering event eliminates or modifies the 60-vote cloture threshold. The Byrd Rule’s reconciliation constraint becomes moot. The existing co-sponsor coalition has a viable path. The opening tests whether the absent industries’ lobbying power, no longer shielded by the procedural barrier, can reconstitute opposition at a different institutional point — the House, the executive, the courts, or the amendment process. Filibuster reform removes the most proximate block but does not dissolve the feedback loop; it relocates the contest. Combined with corrected polling instruments, this is the condition under which the structural diagnosis would face its real-world test.

Corrective and preventive recommendations

Corrective. Filibuster reform eliminating the 60-vote threshold for healthcare legislation, or an alternative procedural pathway through reconciliation-compatible structuring of Medicare for All provisions to survive Byrd Rule points of order. The procedural barrier is the most proximate block; addressing it directly removes the immediate obstacle. Polling instrument standardization requiring that questions about maintaining current insurance explicitly separate public-insurance beneficiaries (Medicare/Medicaid, covering 45 percent of respondents in the Tavern Research survey) from private-insurance holders, to prevent systematically distorted top-line data from driving strategic political counsel against the policy.

Preventive. Campaign-finance reform to reduce the structural industry influence on legislative process that Citizens United v. FEC amplified — this addresses the deeper political-economy enabler that sustains the procedural barrier. Decoupling health coverage from employment and income would prevent coverage gaps from recurring whenever employment or subsidy policy changes, addressing the mounting uninsured count at its institutional source.

Remaining open questions

Would filibuster reform or a Byrd Rule waiver change the legislative calculus, or would organized opposition reconstitute at a different institutional point? The procedural analysis reaches depth 3 and stops at a rule that can be changed, but the political economy underneath it has depth that the analysis cannot fully capture.

Can the 35-cent overhead figure be disaggregated to show which costs genuinely disappear under single-payer and which transfer to a public payer? The displacement question for insurance-industry workers and healthcare administrators depends on implementation design that the hearing record does not supply.

What would polling instruments reveal if they separated respondents already on Medicare or Medicaid from those with private insurance? The corrected numbers exist as a technical possibility — the hearing surfaced the 45 percent sample-composition fact — but the corrected instruments have not been commissioned or published.

What would a hearing that included private insurers, pharmaceutical companies, hospital systems, and state governments as witnesses — not as targets — reveal about whether a negotiated transition is structurally possible? The hearing format was an effective advocacy event but an incomplete diagnostic instrument. The absent parties hold the power to sustain the status quo, and an analysis of what would change their position would require hearing from them directly.

Analytical techniques used in this piece

This analysis applies the methods below. Each links to a short, plain-English explainer you can read and reuse.

Root-Cause Analysis
Traces a symptom back along its causal chain to the conditions that actually generated it.
Scenario Planning
Builds a small set of distinct, plausible futures to plan against.
Stakeholder Mapping
Charts the parties to a situation — their interests, power, and alignments.